Amgen Inc. | AMGN

Healthcare•$185.54B
Article

Analyst Says Viridian's New Thyroid Eye Drug Could Outperform Amgen's Tepezza

Sentiment:3
View Original
Benzinga•Dec 03, 2025•20:25
Expert OpinionPharma/Biotech ClinicalPrice Target Update
Article

Is the Market Bullish or Bearish on Amgen Inc?

Sentiment:5
View Original
Benzinga•Dec 01, 2025•16:00
Breaking News/EventSector Analysis
Article

Jim Cramer Recommends These 4 Dividend Stocks, Says Era Of 'Magical Investing' In AI Is 'Dead'

Sentiment:0
View Original
Benzinga•Nov 28, 2025•15:46